Zimmer Biomet Holdings, Inc. (ZBH): Monthly Stock Report
Publication Date: September 22, 2024
Company Overview
Zimmer Biomet Holdings, Inc. (ZBH), based in Warsaw, Indiana, is a key player in the healthcare sector, specifically within the medical devices industry. Established in 1927, the company specializes in the design, manufacturing, and marketing of orthopedic reconstructive products including knee and hip implants, craniomaxillofacial solutions, and thoracic products. Additionally, Zimmer Biomet provides advanced robotic surgical tools and bone cement essential for treating bone and joint disorders. The company entered the public market on August 7, 2001, aiming to serve healthcare professionals dedicated to improving patient care in orthopedic settings.
Financial Performance and Outlook
Zimmer Biomet reported a total revenue of $7.524 billion, reflecting a strong financial position within the market. Despite the absence of detailed EBITDA data, the revenue figures indicate a solid operational foundation, potentially paving the way for future growth. Currently, the stock price is valued at $106.42, which is approximately 20.5% lower than its 52-week high of $133.90 and above its low of $102.00. Analysts have set a target high price of $145.00, suggesting an upside potential of approximately 36%. The target mean price is estimated at $124.80, aligning closely with the target median of $123.00, reflecting a consensus among 25 analysts that the company holds good investment potential.
Investor Sentiment and Trading Activity
The current stock holds 203,652,000 shares outstanding, with about 5,894,031 shares short, representing roughly 0.0328% of the float of 203,128,988 shares. This low short interest indicates limited bearish sentiment among investors, signaling a relatively high level of confidence in the stock. Analysts collectively recommend a “hold” strategy, with a mean recommendation score of 2.6, suggesting investors maintain their positions rather than engage in new purchases or sales. As the stock trades below its 50-day moving average of $109.70, market participants should remain vigilant for any signs of volatility while navigating key resistance and support levels.
In summary, Zimmer Biomet Holdings, Inc. represents a stable investment opportunity within the orthopedic medical devices sector, backed by solid financials and positive analyst outlooks.
| Metric | Value |
|---|---|
| Market Cap | $21.7b |
| Total Debt | $6.0b |
| Total Cash | $420.1m |
| Shares Outstanding | 203.7m |
| Float Shares | 203.1m |
Disclaimer:
The information provided in this monthly report is for informational purposes only and should not be construed as financial, investment, or trading advice. AltStation.io does not guarantee the accuracy, completeness, or timeliness of the data and analyses presented. The content is based on publicly available information, and while we strive to ensure its accuracy, errors and omissions may occur.
Investing in stocks, cryptocurrencies, and other financial instruments involves significant risk, including the potential loss of principal. Past performance is not indicative of future results. Readers should conduct their own research and consult with a qualified financial advisor before making any investment decisions. AltStation.io and its affiliates are not responsible for any losses incurred as a result of using this report.
By using this report, you acknowledge that you understand and accept these terms.